CROP’s Tenant Hempire Acquires Interest in California Cannabis Distribution & Packaging Company with On Site Extraction
Momentum Public Relations
Press Release: March 22, 2019
CROP INFRASTRUCTURE CORP. (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) announced today that its Humboldt Holdings Tenant Hempire has acquired a 25% interest in a licensed distribution company, with on site non-volatile commercial cannabis manufacturing in California in return for purchasing additional required extraction equipment for the facility. As with all CROP tenant licencees the company’s subsidiary, in this case Humboldt Holdings, will have the right to acquire the licence interest should federal law change in favour of cannabis-THC.
This will allow the Evolution and Hempire to access turn-key equipment to process cannabis flower, cannabis trim and biomass into high-value distillate oil containing tetrahydrocannabinol (THC). The manufacturer will carry the cost of processing cannabis flower, cannabis trim and biomass, getting 40% of the resulting oil sales and CROP and its tenant 60%. The facility is capable of not only processing Hempire’s material but will also be utilized to bring in third party material for processing to develop further SKUS to be sold under the CROP brand portfolio.
CROP brands are expecting to have the 100,000 premium Moon Rock Cones to be ready for the market in short order, with the 50 liters of THC oil being extracted to fill the company’s vape cartridges under the Hempire, Evolution Cannabis and Tiff CBD brands.
Furthermore, the facility will act as the company’s packaging and distribution for all California operations outside of its previously announced distribution agreement giving the company brands exposure to hundreds of potential dispensaries and streamlining its manufacturing and sales process.
CROP CEO, Michael Yorke, stated: “This further vertically integrates CROP’s tenant Hempire in preparation for continued sales in the California market, this will streamline the manufacturing, packaging and distribution of the brands reducing touch points and thus profitability and logistics of production for the California farms.”
About CROP
Crop is publicly listed company trading under symbol CROP.CSE. The company is focused on cannabis branding and real estate assets. CROP’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada cannabis farm, 2,115 acres of Hemp CBD farms, and a growing portfolio of common share equity in upcoming listings within the cannabis space.
CROP has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line and 16 Cannabis brands.
Company Contact
Michael Yorke – CEO and Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: (604) 484-4206
- Published in Cannabis, CROP Infrastructure, Marijuana, News Home
CROP Nevada Development Update
Momentum Public Relations
Press Release: March 20, 2019
CROP INFRASTRUCTURE CORP. (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) announced today the following updates on its Esmeralda County THC and Nye County CBD projects.
Esmeralda Cannabis THC
Trenching is underway with the first shipments of building blocks delivered on site for the construction of the 40-acre perimeter wall for the 2019 outdoor cannabis growing season.
Nye County Hemp CBD
The ground development for the 50,000 square feet of propagation greenhouses is underway and is expected to be completed within the next two weeks. The Micropropagation Team, on site, has begun tissue culturing for task of completing 4,500,000 hemp starters. The company has placed a deposit on 2,000,000 hemp farm bill compliant feminized seeds with delivery expected next month. Nutrients and highly composted fertile soils have been layered over the projects entire 1,350 acres of planned 2019 cultivation. The company also received additional licensing permissions to operate a hemp nursery.
Nevada Extraction
The company has been working with a PhD in Chemistry / Post-Doctorate in molecular pharmacology and biophysics and several engineers to scale CROP’s own solvent-free commercial scale extraction to handle the large amount of hemp biomass and cannabis forecast for the 2019 season. CROP has finalized designs and tender for a ~10 ton per 8-hour shift extraction equipment for its Nevada and Country wide labs.
CROP CEO, Michael Yorke, stated: “These updates represent major progress towards achieving our goal of what will be a very substantial Nevada operation, producing very large quantities of high value product.”
About CROP
Crop is publicly listed company trading under symbol CROP.CSE. The company is focused on cannabis branding and real estate assets. CROP’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada cannabis farm, 2,115 acres of Hemp CBD farms, and a growing portfolio of common share equity in upcoming listings within the cannabis space.
CROP has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line and 16 Cannabis brands.
Company Contact
Michael Yorke – CEO and Director
E-mail: info@cropcorp.comWebsite: www.cropcorp.comPhone: (604) 484-4206
- Published in Cannabis, CROP Infrastructure, Marijuana, News Home
Mondias receives positive results from greenhouse production tests conducted on CELEXT07 with leading cannabis producer
Momentum Public Relations
Press Release: March 18, 2019
Canada NewsWire
MONTREAL, March 18, 2019
- Foliar application of CELEXT07 bio-defense stimulant extract alone or in combination with a botanically-derived antimicrobial plant extract results in the prevention and suppression of powdery mildew on cannabis leaves.
- CELEXT07 is a strong alternative to synthetic fungicides for cannabis growers in search of eco-friendly alternatives.
- CELEXT07 extract is ready to market: production capacity secured to meet demand from potential clients.
MONTREAL, March 18, 2019 /CNW/ – Mondias Naturals Inc. (“Mondias” or the “Company”) (TSXV: NHP) is pleased to announce the results of its greenhouse production tests conducted in collaboration with McGill University and a leading cannabis producer on its proprietary CELEXT07 bio-defense stimulant plant extract.
Mondias has been developing CELEXT07 to help prevent fungal growth on plants through its proven ability to boost plant defense systems. The objective of the tests was to measure the product’s efficacy in reducing and suppressing the most common fungal diseases encountered in cannabis through the application of CELEXT07 alone and in combination with a botanically-derived antimicrobial plant extract grown in greenhouse production systems.
Summary of the test results:
- Preliminary results showed that foliar application of CELEXT07 alone resulted in the prevention of powdery mildew on cannabis leaves.
- Foliar application of CELEXT07 combined with the tested botanically-derived antimicrobial plant extract resulted in the prevention and suppression of powdery mildew on the leaves of three commercial varieties of cannabis. This combination was the most effective in protecting the cannabis variety most susceptible to powdery mildew.
- When applied alone or in combination with the tested botanically-derived antimicrobial plant extract as a foliar spray, CELEXT07 did not produce any phytotoxic effects on cannabis leaves.
- Soil drench application of CELEXT07 helped suppress grey mould on hops, a close relative of cannabis.
“These results validate the effectiveness of CELEXT07’s bio-defense stimulant properties and open up a large potential market for Mondias, especially as the testing was done in collaboration with a leading cannabis producer,” said Jean-Philippe Gravel, Chief Executive Officer of Mondias. “Furthermore, cannabis growers are seeking eco-friendly alternatives to pesticides. The results from these greenhouse production tests will allow us to market CELEXT07 to a growing number of Canadian cannabis producers. The product is ready to market, and we have secured the production capacity we need to meet demand from potential clients.”
With post-harvest losses of one-third of the food produced worldwide for human consumption (Gastavsson et al., 2011) and annual economic losses of $10 billion to $100 billion worldwide due to grey mould and powdery mildew (L. Hua et al., 2018), the market potential for CELEXT07 is considerable.
About Mondias Natural Products Inc.
Mondias specializes in the commercialization and development of evidence-based botanical products for the health care, bio-agriculture and organic markets. The company sells both oral and topical botanical agents to help manage unmet medical needs through its Holizen Laboratories division. Mondias is also developing botanical-based specialty fertilizers for use on household plants, lawns and golf courses and in urban gardens, nurseries and greenhouses, in collaboration with McGill’s Faculty of Agricultural and Environmental Sciences.
For more information, visit: mondias.ca
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, the success of this joint venture, the ability to obtain orphan drug status, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
SOURCE Mondias Natural Products Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2019/18/c6020.html
Contact:
Mondias Natural Products Inc., Jean-Philippe Gravel, Chief Executive Officer, 514-804-4569, jpgravel@mondias.ca
- Published in Cannabis, Life Sciences, Marijuana, Mondias Natural, News Home
Grown Rogue Bringing Proven Growth Model to Large Michigan Cannabis Market for 2019
Momentum Public Relations
Press Release: March 12, 2019
Grown Rogue International Inc. (CSE:GRIN | OTC: NVSIF) (“Grown Rogue” or the “Company”), a vertically-integrated, multi-state cannabis company, with licenses and operations in Oregon and California, is bringing its winning brand and business model which generated compound monthly sales growth of 14% during the 2018 calendar year in Oregon – one of the world’s most competitive cannabis markets – into the newly legalized recreational cannabis market in Michigan. Grown Rogue anticipates gaining meaningful traction for its brand through its local partnership with licensed operators in the State of Michigan.
Oregon is among the most competitive cannabis markets in the United States based on total active cultivation and licenses per capita. According to an August 2018 report from Oregon-Idaho High Intensity Drug Trafficking Area (HIDTA), “Oregon has more than a thousand licensed recreational marijuana growers, with roughly 900 more in the queue to receive licenses. There’s one licensed cultivation operation for every 19 consumers.” Despite this competition, Grown Rogue launched its first cannabis products in late 2017 into the Oregon market and gained sales traction and market share as a result of high-quality products, unique branding and effective marketing. By the end of 2018 Grown Rogue branded products were available in more than half of Oregon dispensaries.
A number of factors contributed to Grown Rogue’s overall success in 2018:
- Optimization of cultivation and distribution teams;
- Major increase in outdoor harvest from 2017 to 2018 by over 50% based on training and efficiency programs implemented in early 2018;
- Accolades in product quality in Oregon by setting outdoor potency record and winning the prestigious Growers Cup in 2 of 3 categories;
- Established partnership with international award winning chocolatier;
- Expansion into California with a 16,000 sq ft micro business facility with retail, processing, and distribution licensing.
“Launching Grown Rogue in Oregon required fastidious planning and execution in order to be successful,” said Obie Strickler, Founder and CEO. “We properly navigated the regulatory environment for recreational cannabis and refined the preferred consumer experience around brands and product selection, and established innovations in product development and packaging. Operating in a State like Oregon that was early to legalize cannabis has provided a tremendous amount of intellectual, operational, and cultivation expertise. We also have significant understanding of the cannabis consumer and evolving cannabis products and formats. We are taking this expertise and applying it into new states and are particularly optimistic about the tremendous opportunity in Michigan.”
Michigan is the first state in the Midwest to vote for the legalization of recreational cannabis . Michiganhas the largest medical cannabis population per capita and is second only to California in total medical users. As a relative comparison, the state of Michigan has a population of approximately 10 million people and about 313,000 registered medical cannabis patients according to Michigan Live, or 3.1%, compared to Canada with a population of approximately 38 million, which had 342,103 registered medical patients at September 30, 2018 according the Health Canada, or 0.9% where cannabis is fully legal at both provincial and federal levels.
By any measure, Michigan has one of the most active medical cannabis markets in America which is a leading indicator in the potential size of the recreational market.
Number of legal medical marijuana patients in the U.S. as of May 2018, by state according to ProCon.org:
STATE |
# OF MEDICAL MARIJUANA PATIENTS |
STATE POPULATION |
# OF PATIENTS PER 1,000 RESIDENTS |
Michigan |
269,553 |
9,9962,311 |
27.06 |
California |
915,845 |
39,536,653 |
23.16 |
Colorado |
88,946 |
5,607,154 |
15.86 |
Oregon |
45,210 |
4,142,776 |
10.91 |
Washington |
80,818 |
7,405,743 |
10.91 |
Massachusetts |
48,265 |
6,859,819 |
7.04 |
Grown Rogue’s current expected portfolio in Michigan includes two strategically positioned retail centers (known as provisional licenses) in Hazel Park and Midtown Detroit as well as a 19,000 sq ft cultivation center in Detroit. Additional license acquisitions are being reviewed.
“Our expansion into Michigan has the potential to add substantial value to the overall business. Our track record of growth to date should give current and future shareholders the confidence that we will continue to perform in the exciting Michigan market,” added Jacques Habra, Chief Strategy Officer.
Grown Rogue expects Michigan operations to begin generating revenue in late 2019.
About Grown Rogue
Grown Rogue International (CSE: GRIN | OTC: NVSIF) is a vertically-integrated, multi-state cannabis company curating innovative products to provide consumers with the right cannabis experience. Each of Grown Rogue’s products and strains are categorized and marketed based on unique effects and designed for the full range of a consumers’ lifestyle. Grown Rogue is scaling the vertically integrated model into multiple states by incorporating best-in-class manufacturing facilities and a proprietary distribution platform based on Microsoft technology. Grown Rogue’s diverse cannabis product suite includes premium flower, patent-pending nitrogen sealed pre-rolls, oil and concentrates, and edibles featuring a partnership with world-renowned chocolatier, Jeff Shepherd.